Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of >37.7 million individuals globally. HF is a shared chronic phase of cardiac functional impairment secondary to many aetiologies, and patients with HF experience a range of symptoms that affect their quality of life, including dyspnoea, fatigue, poor exercise tolerance and fluid retention.

The burden of HF will continue to rise, due to population aging, population growth and improved treatment of HF and other cardiovascular disorders. As a result, clinicians will be increasingly challenged to develop treatment plans and care systems that reduce the high levels of morbidity and mortality experienced by these patients, both from their HF and other comorbidities.

Related Articles


Futility in Transcatheter Aortic Valve Implantation: A Search for Clarity

Kush P Patel, Thomas Treibel, Paul Scully,


Citation: Interventional Cardiology 2022;17:e01.

T1 and T2 Mapping in Uremic Cardiomyopathy: An Update

Luca Arcari, Giovanni Camastra, Federica Ciolina,


Citation: Cardiac Failure Review 2022;8:e02.

Endpoints in Heart Failure Drug Development

Aliza Hussain, Arunima Misra, Biykem Bozkurt,


Citation: Cardiac Failure Review 2022;8:e01.

A Case of Osseocartilaginous Defects and CV Anomalies

Aritra Paul, Aruni Ghose, Debasish Banerjee,


Citation: Journal of Asian Pacific Society of Cardiology 2022;1:e02.